全文获取类型
收费全文 | 49600篇 |
免费 | 3877篇 |
国内免费 | 162篇 |
专业分类
耳鼻咽喉 | 414篇 |
儿科学 | 1591篇 |
妇产科学 | 1254篇 |
基础医学 | 7712篇 |
口腔科学 | 688篇 |
临床医学 | 5253篇 |
内科学 | 10021篇 |
皮肤病学 | 878篇 |
神经病学 | 5746篇 |
特种医学 | 1210篇 |
外科学 | 4750篇 |
综合类 | 425篇 |
一般理论 | 64篇 |
预防医学 | 5687篇 |
眼科学 | 700篇 |
药学 | 3282篇 |
中国医学 | 84篇 |
肿瘤学 | 3880篇 |
出版年
2023年 | 611篇 |
2022年 | 433篇 |
2021年 | 1666篇 |
2020年 | 1312篇 |
2019年 | 1800篇 |
2018年 | 2107篇 |
2017年 | 1430篇 |
2016年 | 1545篇 |
2015年 | 1700篇 |
2014年 | 2104篇 |
2013年 | 2742篇 |
2012年 | 4389篇 |
2011年 | 4348篇 |
2010年 | 2206篇 |
2009年 | 1939篇 |
2008年 | 3123篇 |
2007年 | 3117篇 |
2006年 | 2979篇 |
2005年 | 2789篇 |
2004年 | 2495篇 |
2003年 | 2229篇 |
2002年 | 1917篇 |
2001年 | 357篇 |
2000年 | 324篇 |
1999年 | 358篇 |
1998年 | 335篇 |
1997年 | 266篇 |
1996年 | 206篇 |
1995年 | 229篇 |
1994年 | 166篇 |
1993年 | 150篇 |
1992年 | 189篇 |
1991年 | 198篇 |
1990年 | 169篇 |
1989年 | 170篇 |
1988年 | 132篇 |
1987年 | 139篇 |
1986年 | 137篇 |
1985年 | 119篇 |
1984年 | 100篇 |
1983年 | 100篇 |
1982年 | 67篇 |
1981年 | 76篇 |
1980年 | 59篇 |
1979年 | 77篇 |
1977年 | 57篇 |
1975年 | 49篇 |
1974年 | 50篇 |
1973年 | 48篇 |
1972年 | 48篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
Curren Laura C. Borba Christina P. C. Henderson David C. Tompson Martha C. 《Maternal and child health journal》2022,26(5):1142-1152
Maternal and Child Health Journal - Mothers are especially vulnerable to the onset or recurrence of psychological symptoms during the postpartum period. However, protective psychosocial factors may... 相似文献
3.
Breeze Penny Gray Laura A. Thomas Chloe Bates Sarah E. Brennan Alan 《Quality of life research》2022,31(11):3283-3292
Quality of Life Research - To estimate the association between changes in BMI and changes in Health-Related Quality of Life (EQ-5D-3L). The WRAP trial was a multicentre, randomised controlled trial... 相似文献
4.
5.
Laura A. Huppert MD Ozge Gumusay MD Dame Idossa MD Hope S. Rugo MD 《CA: a cancer journal for clinicians》2023,73(5):480-515
Hormone receptor (HR)-positive and human epidermal growth factor receptor 2 (HER2)-negative breast cancer is defined by the presence of the estrogen receptor and/or the progesterone receptor and the absence of HER2 gene amplification. HR-positive/HER2-negative breast cancer accounts for 65%–70% of all breast cancers, and incidence increases with increasing age. Treatment varies by stage, and endocrine therapy is the mainstay of treatment in both early stage and late-stage disease. Combinations with cyclin-dependent kinase 4/6 inhibitors have reduced distant recurrence in the early stage setting and improved overall survival in the metastatic setting. Chemotherapy is used based on stage and tumor biology in the early stage setting and after endocrine resistance for advanced disease. New therapies, including novel endocrine agents and antibody-drug conjugates, are now changing the treatment landscape. With the availability of new treatment options, it is important to define the optimal sequence of treatment to maximize clinical benefit while minimizing toxicity. In this review, the authors first discuss the pathologic and molecular features of HR-positive/HER2-negative breast cancer and mechanisms of endocrine resistance. Then, they discuss current and emerging therapies for both early stage and metastatic HR-positive/HER2-negative breast cancer, including treatment algorithms based on current data. 相似文献
6.
Mármol-Errasti Esther Cárdenas-Rebollo José Miguel Rodán Antonio Pagán-Fernández Encarnación Jara-García Laura C. Palomo-Álvarez Catalina 《Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie》2022,260(12):3985-3992
Graefe's Archive for Clinical and Experimental Ophthalmology - To characterize accommodative function in secondary school children in year 9 and year 13 and assess the possible relationship... 相似文献
7.
Flor-Alemany Marta Baena-García Laura Migueles Jairo H. Henriksson Pontus Löf Marie Aparicio Virginia A. 《Quality of life research》2022,31(9):2705-2716
Quality of Life Research - The relation between diet and maternal mental health during pregnancy might be relevant to prevent adverse materno-foetal outcomes. This study examined the association of... 相似文献
8.
9.
Olivari Davide De Giorgio Daria Staszewsky Lidia Irene Fumagalli Francesca Boccardo Antonio Novelli Deborah Manfredi Martina Babini Giovanni Luciani Anita Ruggeri Laura Magliocca Aurora Zani Davide Danilo Masson Serge Belloli Angelo Pravettoni Davide Maiocchi Giuseppe Latini Roberto Ristagno Giuseppe 《Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy》2022,36(4):727-738
Cardiovascular Drugs and Therapy - Available animal models of acute heart failure (AHF) and their limitations are discussed herein. A novel and preclinically relevant porcine model of decompensated... 相似文献
10.
Bradshaw Paige Garber Keegan Shaun Foertsch Madeline Yang George L. Ngwenya Laura B. Srinivasan Vasisht 《Journal of thrombosis and thrombolysis》2022,54(2):295-300
Journal of Thrombosis and Thrombolysis - The ongoing controversy regarding optimal reversal agent for factor Xa-inhibitors is mainly due to lack of comparative data of andexanet alfa (AA) to... 相似文献